Ishaque et al. BMC Public Health 2011, 11(Suppl 3):S3 http://www.biomedcentral.com/1471-2458/11/S3/S3 3. Goldenberg RL, Thompson C: The infectious origins of stillbirth. Am J Obstet Gynecol 2003, 189(3):861-873. 4. Herschel M, Hsieh HL, Mittendorf R, Khoshnood B, Covert RF, Lee KS: Fetal death in a population of black women. Am J Prev Med 1995, 11(3):185-189. 5. Goldenberg RL, Hauth JC, Andrews WW: Intrauterine infection and preterm delivery. N Engl J Med 2000, 342(20):1500-1507. 6. Goldenberg RL, Culhane JF, Johnson DC: Maternal infection and adverse fetal and neonatal outcomes. Clin Perinatol 2005, 32(3):523-559. 7. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007, 7(2):93-104. 8. Stegmann BJ, Carey JC: TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. Curr Womens Health Rep 2002, 2(4):253-258. 9. Maruyama Y, Sameshima H, Kamitomo M, Ibara S, Kaneko M, Ikenoue T, Minematsu T, Eizuru Y: Fetal manifestations and poor outcomes of congenital cytomegalovirus infections: possible candidates for intrauterine antiviral treatments. J Obstet Gynaecol Res 2007, 33(5):619-623. 10. Xiong X, Buekens P, Vastardis S, Yu SM: Periodontal disease and pregnancy outcomes: state-of-the-science. Obstet Gynecol Surv 2007, 62(9):605-615. 11. Gursoy M, Pajukanta R, Sorsa T, Kononen E: Clinical changes in periodontium during pregnancy and post-partum. J Clin Periodontol 2008, 35(7):576-583. 12. Cruz SS, Costa Mda C, Gomes-Filho IS, Rezende EJ, Barreto ML, Dos Santos CA, Vianna MI, Passos JS, Cerqueira EM: Contribution of periodontal disease in pregnant women as a risk factor for low birth weight. Community Dent Oral Epidemiol 2009, 37(6):527-533. 13. Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, Ferguson JE, Buchanan W, Bofill J, Papapanou PN, Mitchell DA, et al: Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 2006, 355(18):1885-1894. 14. Polyzos NP, Polyzos IP, Mauri D, Tzioras S, Tsappi M, Cortinovis I, Casazza G: Effect of periodontal disease treatment during pregnancy on preterm birth incidence: a metaanalysis of randomized trials. Am J Obstet Gynecol 2009, 200(3):225-232. 15. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S: Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG 2006, 113(2):135-143. 16. Offenbacher S, Beck JD, Jared HL, Mauriello SM, Mendoza LC, Couper DJ, Stewart DD, Murtha AP, Cochran DL, Dudley DJ, et al: Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol 2009, 114(3):551-559. 17. Haider BA, Humayun Q, Bhutta ZA: Effect of administration of antihelminthics for soil transmitted helminths during pregnancy. Cochrane Database Syst Rev 2009, , 2: CD005547. 18. World Health Organization: WHO Report of the informal consultation on hookworm infection and anaemia in girls and women. (WHO/CTD/SIP/96.1) Geneva: World Health Organization; 1995. 19. Bundy DA, Chan MS, Savioli L: Hookworm infection in pregnancy. Trans R Soc Trop Med Hyg 1995, 89(5):521-522. 20. Walker N, Fischer-Walker C, Bryce J, Bahl R, Cousens S: Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol 2010, 39(Suppl 1):i21-31. 21. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, et al: Grading quality of evidence and strength of recommendations. BMJ 2004, 328(7454):1490. 22. RevMan : The Cochrane Colloboration. Review Manager (RevMan) 5 for Windows. Oxford, England; 2003. 23. Blencowe H, Cousens S, Kamb H, Lawn JE: Detection and treatment of syphillis in pregnancy to prevent syphillis related stillbirths and neonatal mortality. BMC Public Health 2011. 24. Menendez C, Bardaji A, Sigauque B, Romagosa C, Sanz S, Serra-Casas E, Macete E, Berenguera A, David C, Dobano C, et al: A randomized placebo- controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008, 3(4):e1934. 25. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW: Efficacy of sulfadoxine-pyrimethamine for Page 10 of 12 prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998, 59(5):813-822. 26. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K: Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo- controlled trial. Lancet 1999, 353(9153):632-636. 27. Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergstrom S: Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health 2004, 9(10):1066-1073. 28. Dabis F, Elenga N, Meda N, Leroy V, Viho I, Manigart O, Dequae- Merchadou L, Msellati P, Sombie I: 18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS 2001, 15(6):771-779. 29. Limpongsanurak S, Thaithumyanon P, Chaithongwongwatthana S, Thisyakorn U, Ruxrungtham K, Kongsin P, Tarounotai U, Chantheptaewan N, Triratwerapong T, Ubolyam S, et al: Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial. J Med Assoc Thai 2001, 84(Suppl 1):S338-345. 30. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, Chinayon P, et al: Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999, 353(9155):773-780. 31. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, et al: Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d’Ivoire: a randomised trial. Lancet 1999, 353(9155):781-785. 32. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double- blind, placebo-controlled trial. Lancet 2002, 359(9313):1178-1186. 33. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al: Reduction of maternal- infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331(18):1173-1180. 34. McDonald HM, O’Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald PJ: Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997, 104(12):1391-1397. 35. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, et al: Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000, 342(8):534-540. 36. Odendaal HJ, Popov I, Schoeman J, Smith M, Grove D: Preterm labour–is bacterial vaginosis involved? S Afr Med J 2002, 92(3):231-234. 37. Lamont RF, Duncan SL, Mandal D, Bassett P: Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003, 101(3):516-522. 38. Kenyon S, Boulvain M, Neilson J: Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003, 2:CD001058. 39. Flenady V, King J: Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev 2002, 3:CD001807. 40. Drazancic A, Balasa A, Zadjelovic J, Kralj-Pejakovic L: The effect of treatment of bacteriuria on pregnancy outcome. Jugosl Ginekol Perinatol 1989, 29(1-2):15-18. 41. Sheiner E, Mazor-Drey E, Levy A: Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonatal Med 2009, 22(5):423-427. 42. Farrell S, Ide M, Wilson RF: The relationship between maternal periodontitis, adverse pregnancy outcome and miscarriage in never smokers. J Clin Periodontol 2006, 33(2):115-120. 43. Mobeen N, Jehan I, Banday N, Moore J, McClure EM, Pasha O, Wright LL, Goldenberg RL: Periodontal disease and adverse birth outcomes: a study from Pakistan. Am J Obstet Gynecol 2008, 198(5):514 e511-518. 44. Moore S, Ide M, Coward PY, Randhawa M, Borkowska E, Baylis R, Wilson RF: A prospective study to investigate the relationship between periodontal